参考文献
[1]Fujitani K,Yang HK,Mizusawa J,et al.Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA):a phase 3,randomised controlled trial[J].Lancet Oncol.2016,17(3):309-318.
[2]Oasako M,Sakuramoto S,Katai H,et al.Five-year outcomes of a randomized phase Ⅲ trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage Ⅱ or Ⅲ gastric cancer[J].J Clin Oncol.2011,29(33):4387-93.
[3]Qiu MZ,Shi SM,Chen ZH,et al.Frequency and clinicopathological features of metastasis to liver,lung,bone,and brain from gastric cancer:A SEER-based study[J].Cancer Med.2018.7(8):3662-3672.
[4]Al-Batran SE,Homann N,Pauligk C,et al.Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer:The AIO-FLOT3 Trial[J].JAMA Oncol.2017,3(9):1237-1244.
[5]Riihimäki M,Hemminki A,Sundquist K,et al.Metastatic spread in patients with gastric cancer[J].Oncotarget.2016.7(32):52307-52316.
[6]Cheon SH,Rha SY,Jeung HC,et al.Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases[J].Ann Oncol.2008,19(6):1146-53.
[7]中国研究型医院学会消化道肿瘤专业委员会，中国医师协会外科医师分会上消化道外科医师委员会，中国抗癌协会胃癌专业委员会，等.胃癌肝转移诊断与综合治疗中国专家共识（2019版）[J].中国实用外科杂志.2019,39(5):405-411.
[8]Xiao Y,Zhang B,Wu Y.Prognostic analysis and liver metastases relevant factors after gastric and hepatic surgical treatment in gastric cancer patients with metachronous liver metastases:a population-based study[J].Ir J Med Sci.2019,188(2):415-424.
[9]Petrelli F,Coinu A,Cabiddu M,et al.Hepatic resection for gastric cancer liver metastases:A systematic review and meta-analysis[J].J Surg Oncol.2015,111(8):1021-7.
[10]Tatsubayashi T,Tanizawa Y,Miki Y,et al.Treatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imaging[J].Gastric Cancer.2017.20(2):387-393.
[11]Yoshida K,Yamaguchi K,Okumura N,et al.Is conversion therapy possible in stage Ⅳ gastric cancer:the proposal of new biological categories of classification[J].Gastric Cancer.2016.19(2):329-338.
[12]Kodera Y,Fujitani K,Fukushima N,et al.Surgical resection of hepatic metastasis from gastric cancer:a review and new recommendation in the Japanese gastric cancer treatment guidelines[J].Gastric Cancer.2014.17(2):206-12.
[13]Nishi M,Shimada M,Yoshikawa K,et al.Results of Hepatic Resection for Liver Metastasis of Gastric Cancer[J].J Med Invest.2018.65(1.2):27-31.
[14]梁寒.胃癌肝转移诊断与综合治疗中国专家共识解读[J].临床外科杂志.2020.28(1):38-40.
[15]Markar SR,Mikhail S,Malietzis G,et al.Influence of Surgical Resection of Hepatic Metastases From Gastric Adenocarcinoma on Long-term Survival:Systematic Review and Pooled Analysis[J].Ann Surg.2016.263(6):1092-101.
[16]Markar SR,Mackenzie H,Mikhail S,et al.Surgical resection of hepatic metastases from gastric cancer:outcomes from national series in England[J].Gastric Cancer.2017.20(2):379-386.
[17]Shinohara T,Maeda Y,Hamada T,et al.Survival benefit of surgical treatment for liver metastases from gastric cancer[J].J Gastrointest Surg.2015.19(6):1043-51.
[18]Kinoshita T,Kinoshita T,Saiura A,et al.Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases[J].Br J Surg.2015.102(1):102-7.
[19]Oki E,Tokunaga S,Emi Y,et al.Surgical treatment of liver metastasis of gastric cancer:a retrospective multicenter cohort study (KSCC1302)[J].Gastric Cancer.2016.19(3):968-76.
[20]第5版日本《胃癌治疗指南》临床问题解读[J].中国实用外科杂志.2019.39(01):53-69+84.(https://www.daowen.com)
[21]欧海玲，吴留成，覃海泉，等.胃癌肺转移治疗的研究进展[J].中国癌症防治杂志.2020.12(01):99-104.
[22]Nakanishi Y,Ohara M,Domen H,et al.Differences in risk factors between patterns of recurrence in patients after curative resection for advanced gastric carcinoma[J].World J Surg Oncol.2013.11:98.
[23]Kemp CD,Kitano M,Kerkar S,et al.Pulmonary resection for metastatic gastriccancer[J].J Thorac Oncol.2010.5(11):1796-805.
[24]Kanai R,Tane K,Ishii G,et al.Clinical prediction of solitary pulmonary nodule after a curative resection for gastric cancer[J].Jpn J Clin Oncol.2018.48(12):1083-1087.
[25]Chen J,Kong Y,Weng S,et al.Outcomes of surgery for gastric cancer with distant metastases:a retrospective study from the SEER database[J].Oncotarget.2017.8(3):4342-4351.
[26]Sihag S,Muniappan A.Lymph Node Dissection and Pulmonary Metastasectomy[J].Thorac Surg Clin.2016.26(3):315-23.
[27]Al-Batran SE,Hofheinz RD,Pauligk C,et al.Histopathological regression after neoadjuvant docetaxel,oxaliplatin,fluorouracil,and leucovorin versus epirubicin,cisplatin,and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO):results from the phase 2 part of a multicentre,open-label,randomised phase 2/3 trial[J].Lancet Oncol.2016.17(12):1697-1708.
[28]Zhu X,Zhao X,Peng W,et al.Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer:treatment outcomes and analysis of prognostic factors[J].J Cancer Res Clin Oncol.2015.141(1):109-18.
[29]Zaanan A,Palle J,Soularue E,et al.Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma:A Retrospective Multicenter AGEO Study[J].Target Oncol.2018.13(1):107-112.
[30]Palle J,Tougeron D,Pozet A,et al.Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma:a multicenter AGEO study[J].Oncotarget.2017.8(60):101383-101393.
[31]Bang YJ,Van Cutsem E,Feyereislova A,et al.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastrooesophageal junction cancer (ToGA):a phase 3,open-label,randomised controlled trial[J].Lancet.2010.376(9742):687-97.
[32]Dong D,Tang L,Li ZY,et al.Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer[J].Ann Oncol.2019.30(3):431-438.
[33]张维汉，胡建昆.胃癌腹膜转移诊治现状[J].中华胃肠外科杂志.2021.24(03):204-207.
[34]Brenkman H,Päeva M,van Hillegersberg R,et al.Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer-A Systematic Review[J].J Clin Med.2019.8(10).
[35]Yang K,Liu K,Zhang WH,et al.The Value of Palliative Gastrectomy for Gastric Cancer Patients With Intraoperatively Proven Peritoneal Seeding[J].Medicine (Baltimore).2015.94(27):e1051.
[36]中国抗癌协会胃癌专业委员会.胃癌诊治难点中国专家共识（2020版）[J].中国实用外科杂志.2020.40(8):869-904.
[37]宋武，何裕隆.晚期胃癌腹主动脉旁淋巴结转移综合治疗策略[J].中国实用外科杂志.2017.37(10):1102-1106.
[38]吴孟超，吴在德.黄家驷外科学[M].8版.北京：人民卫生出版社，2020.
[39]陈孝平，汪建平，赵继宗.外科学[M].9版.北京：人民卫生出版社，2018.
[40]中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会（CSCO）胃癌治疗指南[M].2021.北京：人民卫生出版社，2021.